Giuseppe Di Giovanni (@gdigiovanni_) 's Twitter Profile
Giuseppe Di Giovanni

@gdigiovanni_

ID: 1923291392

calendar_today01-10-2013 12:20:12

382 Tweet

179 Followers

453 Following

Giuseppe Di Giovanni (@gdigiovanni_) 's Twitter Profile Photo

Impact of lipid lowering on coronary atherosclerosis moving from the lumen to the artery wall 🫀 Steve Nicholls Adam Nelson Dr Kristen Bubb @ yukataoka atherosclerosis-journal.com/article/S0021-…

Frank (@frank_thetank78) 's Twitter Profile Photo

Met some locals in the piazza at Vernazza, Cinque Terre. They taught us about the card game Cirulla. Giuseppe Di Giovanni and Domenic Di Giovanni - we have to learn this game on the next train ride.

Met some locals in the piazza at Vernazza, Cinque Terre. They taught us about the card game Cirulla. 

<a href="/gdigiovanni_/">Giuseppe Di Giovanni</a> and <a href="/dom_digio/">Domenic Di Giovanni</a> - we have to learn this game on the next train ride.
The Asia Pacific Cardiometabolic Consortium (@the_apcmc) 's Twitter Profile Photo

Milestone Alert! 🌟 The GOAL-ASIA Trial, just recruited its 200th participant! We're on a mission to boost heart health and hit those LDL-C targets with a multifaceted intervention. Thanks to everyone involved for their incredible contributions 🎉 #Amgen

Milestone Alert! 🌟 The GOAL-ASIA Trial, just recruited its 200th participant! We're on a mission to boost heart health and hit those LDL-C targets with a multifaceted intervention. Thanks to everyone involved for their incredible contributions 🎉 #Amgen
The Asia Pacific Cardiometabolic Consortium (@the_apcmc) 's Twitter Profile Photo

The GOAL-ASIA Trial has just reached a significant milestone with 300 participants now on board 🌟 Our mission to attain LDL-C targets through a multifaceted intervention and boost heart health is gaining momentum. Thanks to all involved for their amazing support 🎉 #Amgen

The GOAL-ASIA Trial has just reached a significant milestone with 300 participants now on board 🌟 Our mission to attain LDL-C targets through a multifaceted intervention and boost heart health is gaining momentum. Thanks to all involved for their amazing support 🎉 #Amgen
Giuseppe Di Giovanni (@gdigiovanni_) 's Twitter Profile Photo

I’ve been running 4km every day this year. So far, I’ve run 579km over 136 days. My goal is to keep this up for the whole year. I’m doing this to help raise some funds, on behalf of my late father. If you’re able to support please click the link below. walkforlove.org.au/fundraisers/To…

I’ve been running 4km every day this year. So far, I’ve run 579km over 136 days. My goal is to keep this up for the whole year. 

I’m doing this to help raise some funds, on behalf of my late father. If you’re able to support please click the link below.

walkforlove.org.au/fundraisers/To…
Peter Psaltis (@pj_rochester) 's Twitter Profile Photo

Pleased to share the results of the NHMRC and NHF-funded COCOMO-ACS trial. Thanks to the patients, collaborators, site staff and funders who supported us. academic.oup.com/cardiovascres/… SA CVRN SAHMRI AAS Steve Nicholls ChrisBursill Heart Foundation NHMRC Giuseppe Di Giovanni

Giuseppe Di Giovanni (@gdigiovanni_) 's Twitter Profile Photo

I am running 4 km every day of 2024 for my late father, for others fighting cancer and their loved ones MaryPotterFoundation If you'd like to donate please click the link below and follow my progress on Strava Day: 284/366 Total Run Distance: 1,191.1 km mycause.com.au/p/356688/4km-e…

Steve Nicholls (@profsnicholls) 's Twitter Profile Photo

It was a privilege to present the findings of the KRAKEN and BROOKLYN trials at #AHA24 today on behalf of two incredible teams and the patients who play an important role in advancing treatments for heart disease ⁦Monash Victorian Heart Institute⁩ ⁦NewAmsterdam Pharma Corporation⁩ ⁦Eli Lilly and Company

It was a privilege to present the findings of the KRAKEN and BROOKLYN trials at #AHA24 today on behalf of two incredible teams and the patients who play an important role in advancing treatments for heart disease ⁦<a href="/MonashVHI/">Monash Victorian Heart Institute</a>⁩ ⁦<a href="/NewAmsPharma/">NewAmsterdam Pharma Corporation</a>⁩ ⁦<a href="/EliLillyandCo/">Eli Lilly and Company</a>⁩
Monash Victorian Heart Institute (@monashvhi) 's Twitter Profile Photo

Victorian Heart Institute and Hospital Director Steve Nicholls is leading world-first trials for genetic high cholesterol, expanding potentially life-saving treatments for those at risk of heart attack and stroke, presented at American Heart Association. Read: bit.ly/3Zf4IyK

Victorian Heart Institute and Hospital Director <a href="/ProfSNicholls/">Steve Nicholls</a> is leading world-first trials for genetic high cholesterol, expanding potentially life-saving treatments for those at risk of heart attack and stroke, presented at <a href="/American_Heart/">American Heart Association</a>.

Read: bit.ly/3Zf4IyK
Masashi_Fujino MD (@masashifujino) 's Twitter Profile Photo

この数年の脂質低下療法をまとめた総説を執筆しました。Treat-to-targetにも触れていますので、その用語が?な若手の先生は是非一読ください J-STAGE Articles - New Approaches to Lipoproteins for the Prevention of Cardiovascular Events doi.org/10.5551/jat.RV…

Masashi_Fujino MD (@masashifujino) 's Twitter Profile Photo

冠動脈疾患における脂質管理は主にLDL-Cに焦点を当てています。テーラーメイド医療が目指される中、まだ道半ばと感じています。今回、HUYGENS試験のサブ解析を行い、冠動脈プラークの変化におけるApoB目標達成の重要性を明らかにしました。OAなので、ぜひご一読ください! atherosclerosis-journal.com/article/S0021-…

Masashi_Fujino MD (@masashifujino) 's Twitter Profile Photo

Our paper has an editorial comment. We will go on a blind date with LP(a)!! Giuseppe Di Giovanni Steve Nicholls What do recent observations reveal about the ‘blind date’ with Lp(a)-reducing drugs? academic.oup.com/eurjpc/article…